Dapagliflozin improves diastolic performance in an animal model of heart failure with preserved ejection fraction

被引:0
|
作者
Cappetta, D. [1 ]
Urbanek, K. [1 ]
Ciuffreda, L. P. [1 ]
Cozzolino, A. [1 ]
Micciche', A. [1 ]
Coppini, R. [2 ]
Berrino, L. [1 ]
De Angelis, A. [1 ]
机构
[1] Univ Campania Luigi Vanvitelli, Dept Expt Med, Naples, Italy
[2] Univ Florence, Dept Neurosci Drug Res & Childs Hlth NeuroFarBa, Div Pharmacol, Florence, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P634
引用
收藏
页码:165 / 165
页数:1
相关论文
共 50 条
  • [1] Dapagliflozin in Heart Failure with Preserved Ejection Fraction
    Zweck, Elric
    Westenfeld, Ralf
    Redfors, Bjorn
    Omerovic, Elmir
    Weir, Robin A. P.
    Gabrielli, Domenico
    Oliva, Fabrizio
    Zuccala, Giuseppe
    Solomon, Scott D.
    Vaduganathan, Muthiah
    McMurray, John J. V.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (03): : 286 - 286
  • [2] Heart failure with preserved ejection fraction: Is this diastolic heart failure?
    Zile, MR
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (09) : 1519 - 1522
  • [3] Heart failure with preserved ejection fraction (diastolic heart failure)
    Güder G.
    Ertl G.
    MMW - Fortschritte der Medizin, 2019, 161 (9) : 58 - 65
  • [4] Empagliflozin Improves Diastolic Function in a Nondiabetic Rodent Model of Heart Failure With Preserved Ejection Fraction
    Connelly, Kim A.
    Zhang, Yanling
    Visram, Aylin
    Advani, Andrew
    Batchu, Sri N.
    Desjardins, Jean-Francois
    Thai, Kerri
    Gilbert, Richard E.
    JACC-BASIC TO TRANSLATIONAL SCIENCE, 2019, 4 (01): : 27 - 37
  • [5] The treatment of heart failure with preserved ejection fraction (“diastolic heart failure”)
    Karen Hogg
    John McMurray
    Heart Failure Reviews, 2006, 11 : 141 - 146
  • [6] Diastolic heart failure. Heart failure with preserved ejection fraction
    Dovjak, P.
    ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2013, 46 (01): : 71 - 81
  • [7] The treatment of heart failure with preserved ejection fraction ("diastolic heart failure")
    Hogg, Karen
    McMurray, John
    HEART FAILURE REVIEWS, 2006, 11 (02) : 141 - 146
  • [8] Heart Failure With Preserved Ejection Fraction (Diastolic Dysfunction)
    Meyer, Theo
    Shih, Jeffrey
    Aurigemma, Gerard
    ANNALS OF INTERNAL MEDICINE, 2013, 158 (01)
  • [9] Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
    Solomon, S. D.
    McMurray, J. J., V
    Claggett, B.
    de Boer, R. A.
    DeMets, D.
    Hernandez, A. F.
    Inzucchi, S. E.
    Kosiborod, M. N.
    Lam, C. S. P.
    Martinez, F.
    Shah, S. J.
    Desai, A. S.
    Jhund, P. S.
    Belohlavek, J.
    Chiang, C-E
    Borleffs, C. J. W.
    Comin-Colet, J.
    Dobreanu, D.
    Drozdz, J.
    Fang, J. C.
    Alcocer-Gamba, M. A.
    Al Habeeb, W.
    Han, Y.
    Cabrera Honorio, J. W.
    Janssens, S. P.
    Katova, T.
    Kitakaze, M.
    Merkely, B.
    O'Meara, E.
    Saraiva, J. F. K.
    Tereshchenko, S. N.
    Thierer, J.
    Vaduganathan, M.
    Vardeny, O.
    Verma, S.
    Pham, V. N.
    Wilderang, U.
    Zaozerska, N.
    Bachus, E.
    Lindholm, D.
    Petersson, M.
    Langkilde, A. M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, : 1089 - 1098
  • [10] Dapagliflozin in Heart Failure with Preserved Ejection Fraction-Reply
    Kjaergaard, Jesper
    Moller, Jacob E.
    Hassager, Christian
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (03): : 285 - 286